Related Experiment Videos
Assessing differences in clinical trials comparing surgical vs nonsurgical therapy: using common (statistical) sense
G Howard1, L E Chambless, R A Kronmal
1Department of Public Health Sciences, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, NC, USA.
JAMA
|November 14, 1997
Summary
Clinical trials comparing surgical and nonsurgical treatments face challenges due to changing risks over time. Survival analyses must account for this to guide optimal patient treatment decisions.
Area of Science:
- Medical Statistics
- Clinical Trial Design
- Surgical Outcomes
Background:
- Comparing surgical vs. nonsurgical treatments presents statistical challenges due to differing risk profiles over time.
- Standard survival analyses often assume constant risk ratios, which may not reflect reality when risks change differentially between treatments.
- The relative efficacy of treatments can vary depending on the follow-up duration, complicating direct comparisons.
Purpose of the Study:
- To address the complexities of statistical hypothesis testing and test selection in clinical trials comparing surgical and nonsurgical interventions.
- To explore alternative hypothesis statements that better align with patient time horizons and clinical judgment.
- To guide the interpretation of survival data in the context of treatment choice and individual patient factors.
Main Methods:
- Review of common statistical survival analyses and their limitations in the context of time-varying risks.
- Discussion of alternative hypothesis formulations considering patient time horizons and clinical relevance.
- Emphasis on individualized treatment decisions based on risk-benefit trade-offs and patient-specific factors.
Main Results:
- Traditional survival analyses may oversimplify the comparison of surgical versus nonsurgical treatments when risk profiles evolve differently.
- Crossing survival curves indicate a trade-off between surgical risk and long-term survival benefits for survivors.
- The choice of statistical methods should be carefully considered to reflect the dynamic nature of treatment risks.
Conclusions:
- Selecting the best treatment requires moving beyond simple survival curve comparisons to consider the time horizon and individual patient characteristics.
- Clinical trial outcomes should provide information for both generalizable conclusions and individualized decision-making.
- Patient-specific factors like life expectancy, risk tolerance, quality of life, and cost are crucial for informed treatment choices.